Literature DB >> 23483057

A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation.

Mi Hyun Bae1, Hyun-Ki Kim, Chan-Jeoung Park, Eul-Ju Seo, Sang Hyuk Park, Young-Uk Cho, Seongsoo Jang, Hyun-Sook Chi, Kyu-Hyung Lee.   

Abstract

In up to 40% of systemic mastocytosis (SM) cases, an associated clonal hematological non-mast cell lineage disease such as AML is diagnosed before, simultaneously with, or after the diagnosis of SM. A 40-yr-old man was diagnosed with AML with t(8;21)(q22;q22). Mast cells were not noted at diagnosis, but appeared as immature forms at relapse. After allogeneic hematopoietic stem cell transplantation (HSCT), leukemic myeloblasts were not observed; however, neoplastic metachromatic blasts strikingly proliferated during the state of bone marrow aplasia, and finally, aleukemic mast cell leukemia developed. As the disease progressed, we observed serial morphologic changes from immature mast cells with myeloblasts to only metachromatic blasts and atypical mast cells as mast cell leukemia; FISH analysis showed that the neoplastic mast cells originated from the same clone as the leukemic myeloblasts of AML.

Entities:  

Keywords:  Acute myeloid leukemia; Aleukemic mast cell leukemia; Allogeneic hematopoietic stem cell transplantation; Systemic mastocytosis

Mesh:

Year:  2013        PMID: 23483057      PMCID: PMC3589638          DOI: 10.3343/alm.2013.33.2.125

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN: 2234-3806            Impact factor:   3.464


  14 in total

1.  Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.

Authors:  Wolfgang R Sperr; Johannes Drach; Alexander W Hauswirth; Jutta Ackermann; Margit Mitterbauer; Gerlinde Mitterbauer; Manuela Foedinger; Christa Fonatsch; Ingrid Simonitsch-Klupp; Peter Kalhs; Peter Valent
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

2.  KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.

Authors:  Susanne Schnittger; Tobias M Kohl; Torsten Haferlach; Wolfgang Kern; Wolfgang Hiddemann; Karsten Spiekermann; Claudia Schoch
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

Review 3.  Hematologic aspects of systemic mastocytosis.

Authors:  R I Parker
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

Review 4.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 5.  Mastocytosis: pathology, genetics, and current options for therapy.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Matthias Mayerhofer; Manuela Födinger; Robert Fritsche-Polanz; Karl Sotlar; Luis Escribano; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Leuk Lymphoma       Date:  2005-01

6.  Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.

Authors:  Luis Escribano; Andrés Garca-Montero; Rosa Núñez-López; Javier López-Jiménez; Julia Almeida; Aranzazu Prados; Alberto Orfao
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

7.  Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation.

Authors:  A Spyridonidis; A K Thomas; H Bertz; R Zeiser; A Schmitt-Gräff; A Lindemann; C F Waller; J Finke
Journal:  Bone Marrow Transplant       Date:  2004-09       Impact factor: 5.483

8.  Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.

Authors:  W R Sperr; S Walchshofer; H P Horny; M Födinger; I Simonitsch; R Fritsche-Polanz; I Schwarzinger; E Tschachler; C Sillaber; W Hagen; K Geissler; A Chott; K Lechner; P Valent
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

Review 9.  Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.

Authors:  H-W Bernd; K Sotlar; J Lorenzen; R Osieka; U Fabry; P Valent; H-P Horny
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

10.  Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation.

Authors:  T-Y Chen; J-S Chen; W-T Huang; W-C Su; C-J Tsao
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

View more
  6 in total

Review 1.  Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Authors:  P Valent; K Sotlar; W R Sperr; L Escribano; S Yavuz; A Reiter; T I George; H C Kluin-Nelemans; O Hermine; J H Butterfield; H Hägglund; C Ustun; J L Hornick; M Triggiani; D Radia; C Akin; K Hartmann; J Gotlib; L B Schwartz; S Verstovsek; A Orfao; D D Metcalfe; M Arock; H-P Horny
Journal:  Ann Oncol       Date:  2014-03-27       Impact factor: 32.976

2.  De novo leukemic variant of mast cell leukemia with KIT D816V.

Authors:  Hae In Bang; Rojin Park; Eun Su Park; In Ho Choi; Kyoung Ha Kim; Jeong Won Shin; Tae Youn Choi; Kyungja Han; Jong-Ho Won
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

Review 3.  (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia.

Authors:  Ji Yoon Lee; Hee-Je Kim
Journal:  Exp Mol Med       Date:  2014-11-21       Impact factor: 8.718

4.  Acute Myeloid Leukemia With Inv(16)(p13q22) Associated With Hidden Systemic Mastocytosis: Case Report and Review of Literature.

Authors:  Feryal Abbas Ibrahim Hilmi; Ahmad Al-Sabbagh; Dina Sameh Soliman; Hesham Al Sabah; Omar Mohammad Ismail; Mohamed Yassin; Halima El-Omri
Journal:  Clin Med Insights Blood Disord       Date:  2017-03-30

5.  KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia.

Authors:  Marta Lopes; Maria Dos Anjos Teixeira; Cláudia Casais; Vanessa Mesquita; Patrícia Seabra; Renata Cabral; José Palla-García; Catarina Lau; João Rodrigues; Maria Jara-Acevedo; Inês Freitas; Jose Ramón Vizcaíno; Jorge Coutinho; Luis Escribano; Alberto Orfao; Margarida Lima
Journal:  Case Rep Hematol       Date:  2018-02-18

Review 6.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.